Skip to main content
LivaNova PLC logo

LivaNova PLC — Investor Relations & Filings

Ticker · LIVN ISIN · GB00BYMT0J19 LEI · 2138001K2FX6SHK2B339 US Manufacturing
Filings indexed 943 across all filing types
Latest filing 2016-05-13 Major Shareholding Noti…
Country GB United Kingdom
Listing US LIVN

About LivaNova PLC

https://www.livanova.com/

LivaNova PLC is a global medical technology company that designs, develops, and manufactures devices and therapies focused on neurological and cardiac conditions. The company operates through two primary business segments: Neuromodulation and Cardiopulmonary. The Neuromodulation portfolio features Vagus Nerve Stimulation (VNS) Therapy™, a treatment for drug-resistant epilepsy and difficult-to-treat depression. The Cardiopulmonary segment provides a comprehensive suite of products essential for open-heart surgery, including heart-lung machines, such as the Essenz™ Perfusion System, oxygenators, and autotransfusion systems. LivaNova is dedicated to creating innovative medical solutions to address significant unmet patient needs and improve health outcomes.

Recent filings

Filing Released Lang Actions
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Notification of Major Interest in Shares', which is a standard regulatory form used in the UK and other jurisdictions to report when a shareholder crosses specific voting rights thresholds (e.g., 3%, 5%, etc.). This aligns perfectly with the definition of a 'Major Shareholding Notification'.
2016-05-13 English
13G/A FILING
Major Shareholding Notification
2016-05-12 English
FORM 4
Director's Dealing
2016-05-10 English
10-Q 2016.03.31
Interim / Quarterly Report Q1 2016
2016-05-09 English
LIVANOVA Q1 EARNINGS RELEASE
Regulatory Filings
2016-05-04 English
PRE 14A
Regulatory Filings
2016-05-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.